167 related articles for article (PubMed ID: 36444864)
21. Predicting Major Bleeding in Ischemic Stroke Patients With Atrial Fibrillation.
Hilkens NA; Algra A; Greving JP
Stroke; 2017 Nov; 48(11):3142-3144. PubMed ID: 28931618
[TBL] [Abstract][Full Text] [Related]
22. Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores. The Murcia Atrial Fibrillation Project.
Esteve-Pastor MA; Rivera-Caravaca JM; Roldan V; Vicente V; Valdés M; Marín F; Lip GYH
Thromb Haemost; 2017 Oct; 117(10):1848-1858. PubMed ID: 28799620
[TBL] [Abstract][Full Text] [Related]
23. Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trial.
Proietti M; Hijazi Z; Andersson U; Connolly SJ; Eikelboom JW; Ezekowitz MD; Lane DA; Oldgren J; Roldan V; Yusuf S; Wallentin L;
J Intern Med; 2018 Mar; 283(3):282-292. PubMed ID: 29044861
[TBL] [Abstract][Full Text] [Related]
24. The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study.
Hijazi Z; Oldgren J; Lindbäck J; Alexander JH; Connolly SJ; Eikelboom JW; Ezekowitz MD; Held C; Hylek EM; Lopes RD; Siegbahn A; Yusuf S; Granger CB; Wallentin L;
Lancet; 2016 Jun; 387(10035):2302-2311. PubMed ID: 27056738
[TBL] [Abstract][Full Text] [Related]
25. Risk scores for major bleeding from direct oral anticoagulants: comparing predictive performance in patients with atrial fibrillation.
Campos-Staffico AM; Jacoby JP; Dorsch MP; Limdi NA; Barnes GD; Luzum JA
Res Pract Thromb Haemost; 2024 Jan; 8(1):102285. PubMed ID: 38292348
[TBL] [Abstract][Full Text] [Related]
26. Effects of rivaroxaban and warfarin on the risk of gastrointestinal bleeding and intracranial hemorrhage in patients with atrial fibrillation: Systematic review and meta-analysis.
Jiang H; Jiang Y; Ma H; Zeng H; Lv J
Clin Cardiol; 2021 Sep; 44(9):1208-1215. PubMed ID: 34302375
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular, Bleeding, and Mortality Risks of Dabigatran in Asians With Nonvalvular Atrial Fibrillation.
Chan YH; Yen KC; See LC; Chang SH; Wu LS; Lee HF; Tu HT; Yeh YH; Kuo CT
Stroke; 2016 Feb; 47(2):441-9. PubMed ID: 26732563
[TBL] [Abstract][Full Text] [Related]
28. Usefulness of the CHA
Jaakkola S; Kiviniemi TO; Nuotio I; Hartikainen J; Mustonen P; Palomäki A; Jaakkola J; Ylitalo A; Hartikainen P; Airaksinen KEJ
Am J Cardiol; 2018 May; 121(10):1182-1186. PubMed ID: 29526276
[TBL] [Abstract][Full Text] [Related]
29. Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
Garcia DA; Fisher DA; Mulder H; Wruck L; De Caterina R; Halvorsen S; Granger CB; Held C; Wallentin L; Alexander JH; Lopes RD
Am Heart J; 2020 Mar; 221():1-8. PubMed ID: 31896036
[TBL] [Abstract][Full Text] [Related]
30. Incident Risk Factors and Major Bleeding in Patients with Atrial Fibrillation Treated with Oral Anticoagulants: A Comparison of Baseline, Follow-up and Delta HAS-BLED Scores with an Approach Focused on Modifiable Bleeding Risk Factors.
Chao TF; Lip GYH; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Chen SA
Thromb Haemost; 2018 Apr; 118(4):768-777. PubMed ID: 29510426
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic Accuracy of the HAS-BLED Bleeding Score in VKA- or DOAC-Treated Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Gao X; Cai X; Yang Y; Zhou Y; Zhu W
Front Cardiovasc Med; 2021; 8():757087. PubMed ID: 34881309
[No Abstract] [Full Text] [Related]
32. External Validation of the ORBIT Bleeding Score and the HAS-BLED Score in Nonvalvular Atrial Fibrillation Patients Using Direct Oral Anticoagulants (Asian Data from the DIRECT Registry).
Mori N; Sotomi Y; Hirata A; Hirayama A; Sakata Y; Higuchi Y
Am J Cardiol; 2019 Oct; 124(7):1044-1048. PubMed ID: 31353002
[TBL] [Abstract][Full Text] [Related]
33. Comparative Effectiveness of Machine Learning Approaches for Predicting Gastrointestinal Bleeds in Patients Receiving Antithrombotic Treatment.
Herrin J; Abraham NS; Yao X; Noseworthy PA; Inselman J; Shah ND; Ngufor C
JAMA Netw Open; 2021 May; 4(5):e2110703. PubMed ID: 34019087
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: the AMADEUS trial.
Apostolakis S; Lane DA; Buller H; Lip GY
Thromb Haemost; 2013 Nov; 110(5):1074-9. PubMed ID: 24048467
[TBL] [Abstract][Full Text] [Related]
35. Risks of Bleeding and Stroke Based on CHA2DS2-VASc Scores in Japanese Patients With Atrial Fibrillation: A Large-Scale Observational Study Using Real-World Data.
Maeda T; Nishi T; Funakoshi S; Tada K; Tsuji M; Satoh A; Kawazoe M; Yoshimura C; Arima H
J Am Heart Assoc; 2020 Mar; 9(5):e014574. PubMed ID: 32106743
[TBL] [Abstract][Full Text] [Related]
36. Accuracy of HAS-BLED and other bleeding risk assessment tools in predicting major bleeding events in atrial fibrillation: A network meta-analysis.
Chang G; Xie Q; Ma L; Hu K; Zhang Z; Mu G; Cui Y
J Thromb Haemost; 2020 Apr; 18(4):791-801. PubMed ID: 31782613
[TBL] [Abstract][Full Text] [Related]
37. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
38. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?
Ruiz-Nodar JM; Marín F; Roldán V; Valencia J; Manzano-Fernández S; Caballero L; Hurtado JA; Sogorb F; Valdés M; Lip GY
Circ Cardiovasc Interv; 2012 Aug; 5(4):459-66. PubMed ID: 22787018
[TBL] [Abstract][Full Text] [Related]
39. Performance of bleeding risk-prediction scores in patients with atrial fibrillation undergoing percutaneous coronary intervention.
Kiviniemi T; Puurunen M; Schlitt A; Rubboli A; Karjalainen P; Vikman S; Niemelä M; Lahtela H; Lip GY; Airaksinen KE
Am J Cardiol; 2014 Jun; 113(12):1995-2001. PubMed ID: 24793675
[TBL] [Abstract][Full Text] [Related]
40. HAS-BLED vs. ORBIT scores in anticoagulated patients with atrial fibrillation: A systematic review and meta-analysis.
Liu X; Wang S; He W; Guo L
Front Cardiovasc Med; 2022; 9():1042763. PubMed ID: 36684554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
